drugset / Trial / NCT03266601
Effect of Recombinant Human Interferon α-2b Spray on Herpangina
Phase 4
Completed
668 enrolled
Children's Hospital of Fudan University
Anhui Provincial Children's Hospital · collabChanghai Hospital · collabChildren's Hospital of Chongqing Medical University · collabChildren's Hospital of Kaifeng City · collabHunan Children's Hospital · collabQilu Children's Hospital of Shandong University · collabShenzhen Children's Hospital · collabTianjin Sinobioway Biomedicine Co.Ltd. · collabYuying Children's Hospital of Wenzhou Medical University · collabZunyi Medical College · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multicenter, open，randomized controlled trial aiming to evaluate the effectiveness of recombinant human interferon α-2b spray compared with ribavirin treatment on pediatric patients with herpangina.
Timeline
- Start
- 2016-06-01
- Primary completion
- 2018-11-30
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Human Interferon α2b | Protein / enzyme biologic | 1e+06 iu | Other |
| Comparator | Ribavirin | Small molecule | — | Other |